Posts in tag

biosimilars


Biosimilars and the pharmacist’s role in their supply remains controversial, writes Carlene McMaugh Biological pharmaceutical products have been a part of the landscape of therapeutics for a number of years …

Here’s what you need to know While there are not many biosimilars available yet in Australia, several have been added to the ARTG and PBS this year. Biosimilar medicines are …

A recent survey found that pharmacist comfort with supplying biosimilars is going backward, so what can be done to turn this around? In 2018, 361 community pharmacists were surveyed across …

Pharmacists’ authority to use their expertise to substitute one medicine for another should also apply to biological medicines, says FIP The International Pharmaceutical Federation has published a revised Statement of …

Guild Learning and Development is partnering with MSD Australia in an online course titled Biosimilars in focus This is the first of two courses to be launched on this topic …

Medicines Australia and the Government have signed a five-year agreement which will see innovative medicines reduced in price over 15 years The organisation says the Strategic Agreement will support ongoing …

While they present a cost-saving opportunity, safety data on biosimilars is still limited, warns IBD specialist There is an absence of data on adverse reactions or potential development of anti-drug …

The way a biosimilar is named may affect whether a pharmacist is willing to substitute it for a brand name biologic, a new study has found. The study, published in …

The inclusion of the first monoclonal antibody biosimilar on the PBS will deliver immediate savings to the Federal Government; however the full potential of this and other biosimilar medicines relies …

Pfizer today confirmed that the first mAb biosimilar, Inflectra (infliximab), will be added to the PBS on 1 December 2015 for the treatment of eight inflammatory conditions.

Four policy priorities that will safeguard affordable access to medicines in Australia while ensuring the generic and biosimilar medicines industry remains viable have been agreed to by the Federal Government. …

The Department of Health is seeking feedback on the Implementation Framework for the Biosimilars Awareness project. The Department of Health says the aim of the project is improve awareness and …